Antiphosphatidylethanolamine antibody as a marker of antiphospholipid syndrome?

被引：1

作者：

Yelnik, Cecile Marie ^{[1
]}

Dubucquoi, Sylvain ^{[2
]}

Houfflin-Debarge, Veronique ^{[3
]}

Lambert, Marc ^{[1
]}

机构：

[1] CHRU Lille, Hop Huriez, Serv Med Interne & Explorat Vasc, F-59037 Lille, France

[2] CHRU Lille, Inst Immunol, Ctr Biol Pathol Genet Med, F-59037 Lille, France

[3] CHRU Lille, Matern Jeanne de Flandres, Serv Pathol Obstet, F-59037 Lille, France

来源：

PRESSE MEDICALE | 2015年 / 44卷 / 03期

关键词：

SYSTEMIC-LUPUS-ERYTHEMATOSUS; PHOSPHATIDYLETHANOLAMINE APE; PREGNANCY LOSS; THROMBOSIS; AUTOANTIBODIES; RECOGNIZE; DIAGNOSIS; FAILURE; TESTS; ELISA;

D O I：

10.1016/j.lpm.2014.06.033

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Antibody to phosphatidylethanolamine (aPE) are observed in thrombotic or obstetric manifestations suggestive of antiphospholipid syndrome (APS). aPE seem to be markers of thrombotic risk independent of conventional antiphospholipid antibodies (aPL). aPE assays are not standardized. There is no therapeutic recommendation for isolated aPE patients with thromboticor obstetric events. Prospective studies have to be carried to better define the therapeutic management of these patients. Value of aPE in APS criteria is still not established.

引用

页码：284 / 291

页数：8

共 33 条

[1]

Balada E, 2001, SCAND J RHEUMATOL, V30, P235

[2] Phosphatidylethanolamine critically supports internalization of cell-penetrating protein C inhibitor [J].

Baumgaertner, Petra ;

Geiger, Margarethe ;

Zieseniss, Susanne ;

Malleier, Julia ;

Huntington, James A. ;

Hochrainer, Karin ;

Bielek, Edith ;

Stoeckelhuber, Mechthild ;

Lauber, Kirsten ;

Scherfeld, Dag ;

Schwille, Petra ;

Waeldele, Katja ;

Beyer, Klaus ;

Engelmann, Bernd .

JOURNAL OF CELL BIOLOGY, 2007, 179 (04) :793-804

[3] Influence of the phosphatidylethanolamine (PE) and bovine serum origins on anti-PE antibody detection by ELISA [J].

Berard, M ;

Boffa, MC .

THROMBOSIS RESEARCH, 1997, 85 (05) :439-442

[4] The clinical value of testing for antibodies to phosphatidylethanolamine (aPE) in patients with systemic lupus erythematosus (SLE) [J].

Bertolaccini, M. L. ;

Murru, V. ;

Sciascia, S. ;

Sanna, G. ;

Khamashta, M. A. .

THROMBOSIS RESEARCH, 2012, 130 (06) :914-918

[5] 'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010 [J].

Bertolaccini, M. L. ;

Amengual, O. ;

Atsumi, T. ;

Binder, W. L. ;

de laat, B. ;

Forastiero, R. ;

Kutteh, W. H. ;

Lambert, M. ;

Matsubayashi, H. ;

Murthy, V. ;

Petri, M. ;

Rand, J. H. ;

Sanmarco, M. ;

Tebo, A. E. ;

Pierangeli, S. S. .

LUPUS, 2011, 20 (02) :191-205

[6]

Bertolaccini ML, 1998, BRIT J RHEUMATOL, V37, P1229

[7]

Gonzales-Portillo F, 2001, J Stroke Cerebrovasc Dis, V10, P222, DOI 10.1053/jscd.2001.29818

[8]

Gris JC, 2000, THROMB HAEMOSTASIS, V84, P228

[9] Laboratory Evaluation of Antiphospholipid Antibodies in Patients With Venous Thromboembolism [J].

Hirmerova, J. ;

Ulcova-Gallova, Z. ;

Seidlerova, J. ;

Filipovsky, J. ;

Bibkova, K. ;

Micanova, Z. ;

Mayer, O., Jr. .

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2010, 16 (03) :318-325

[10] Seronegative antiphospholipid syndrome [J].

Hughes, GRV ;

Khamashta, MA .

ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (12) :1127-1127

← 1 2 3 4 →